AMN Healthcare Services (AMN) Competitors

$36.74 -0.10 (-0.27%)

Closing price 03:59 PM Eastern

Extended Trading

$36.72 -0.02 (-0.07%)

As of 04:04 PM Eastern

AMN vs. EYE, MEDP, VEEV, WST, and LFST

Should you buy AMN Healthcare Services stock or one of its competitors? AMN Healthcare Services's main competitors and comparable companies include National Vision (EYE), Medpace (MEDP), Veeva Systems (VEEV), West Pharmaceutical Services (WST), and LifeStance Health Group (LFST). Companies are selected based on similarities in market, industry, and size.

How does AMN Healthcare Services compare to National Vision?

National Vision (NASDAQ:EYE) and AMN Healthcare Services (NYSE:AMN) are related small-cap companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

National Vision currently has a consensus target price of $29.82, indicating a potential upside of 80.50%. AMN Healthcare Services has a consensus target price of $36.00, indicating a potential downside of 2.26%. Given National Vision's stronger consensus rating and higher probable upside, equities analysts clearly believe National Vision is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.64
AMN Healthcare Services	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, National Vision had 2 more articles in the media than AMN Healthcare Services. MarketBeat recorded 2 mentions for National Vision and 0 mentions for AMN Healthcare Services. National Vision's average media sentiment score of 1.02 beat AMN Healthcare Services' score of 0.00 indicating that National Vision is being referred to more favorably in the media.

Company	Overall Sentiment
National Vision	Positive
AMN Healthcare Services	Neutral

National Vision has a beta of 0.98, suggesting that its share price is 2% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, suggesting that its share price is 60% less volatile than the broader market.

AMN Healthcare Services has a net margin of 3.06% compared to National Vision's net margin of 2.47%. AMN Healthcare Services' return on equity of 19.92% beat National Vision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	2.47%	6.78%	3.01%
AMN Healthcare Services	3.06%	19.92%	5.93%

99.2% of AMN Healthcare Services shares are owned by institutional investors. 2.4% of National Vision shares are owned by company insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

National Vision has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$2.03B	0.64	$29.60M	$0.61	27.08
AMN Healthcare Services	$2.73B	0.52	-$95.70M	$2.68	13.74

Summary

National Vision beats AMN Healthcare Services on 10 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to Medpace?

AMN Healthcare Services (NYSE:AMN) and Medpace (NASDAQ:MEDP) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

Medpace has a net margin of 17.67% compared to AMN Healthcare Services' net margin of 3.06%. Medpace's return on equity of 110.15% beat AMN Healthcare Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	3.06%	19.92%	5.93%
Medpace	17.67%	110.15%	24.84%

AMN Healthcare Services presently has a consensus price target of $36.00, suggesting a potential downside of 2.26%. Medpace has a consensus price target of $602.27, suggesting a potential downside of 2.94%. Given AMN Healthcare Services' stronger consensus rating and higher possible upside, equities analysts plainly believe AMN Healthcare Services is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Medpace	0 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.23

In the previous week, Medpace had 24 more articles in the media than AMN Healthcare Services. MarketBeat recorded 24 mentions for Medpace and 0 mentions for AMN Healthcare Services. Medpace's average media sentiment score of 0.41 beat AMN Healthcare Services' score of 0.00 indicating that Medpace is being referred to more favorably in the news media.

Company	Overall Sentiment
AMN Healthcare Services	Neutral
Medpace	Neutral

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by company insiders. Comparatively, 20.5% of Medpace shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Medpace has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.52	-$95.70M	$2.68	13.74
Medpace	$2.78B	6.22	$451.12M	$17.06	36.37

AMN Healthcare Services has a beta of 0.4, meaning that its share price is 60% less volatile than the broader market. Comparatively, Medpace has a beta of 1.18, meaning that its share price is 18% more volatile than the broader market.

Summary

Medpace beats AMN Healthcare Services on 12 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to Veeva Systems?

AMN Healthcare Services (NYSE:AMN) and Veeva Systems (NYSE:VEEV) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

In the previous week, Veeva Systems had 17 more articles in the media than AMN Healthcare Services. MarketBeat recorded 17 mentions for Veeva Systems and 0 mentions for AMN Healthcare Services. Veeva Systems' average media sentiment score of 0.29 beat AMN Healthcare Services' score of 0.00 indicating that Veeva Systems is being referred to more favorably in the news media.

Company	Overall Sentiment
AMN Healthcare Services	Neutral
Veeva Systems	Neutral

AMN Healthcare Services currently has a consensus target price of $36.00, indicating a potential downside of 2.26%. Veeva Systems has a consensus target price of $284.88, indicating a potential upside of 0.54%. Given Veeva Systems' stronger consensus rating and higher possible upside, analysts plainly believe Veeva Systems is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Veeva Systems	1 Sell rating(s)	8 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.64

Veeva Systems has a net margin of 29.34% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat Veeva Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	3.06%	19.92%	5.93%
Veeva Systems	29.34%	14.25%	11.71%

AMN Healthcare Services has a beta of 0.4, meaning that its stock price is 60% less volatile than the broader market. Comparatively, Veeva Systems has a beta of 0.93, meaning that its stock price is 7% less volatile than the broader market.

Veeva Systems has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Veeva Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.52	-$95.70M	$2.68	13.74
Veeva Systems	$3.20B	14.36	$908.91M	$6.08	46.60

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 88.2% of Veeva Systems shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by insiders. Comparatively, 10.6% of Veeva Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Veeva Systems beats AMN Healthcare Services on 14 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to West Pharmaceutical Services?

AMN Healthcare Services (NYSE:AMN) and West Pharmaceutical Services (NYSE:WST) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, profitability and risk.

AMN Healthcare Services has a beta of 0.4, meaning that its stock price is 60% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.13, meaning that its stock price is 13% more volatile than the broader market.

AMN Healthcare Services presently has a consensus price target of $36.00, indicating a potential downside of 2.26%. West Pharmaceutical Services has a consensus price target of $382.00, indicating a potential upside of 1.42%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, analysts clearly believe West Pharmaceutical Services is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.86

In the previous week, West Pharmaceutical Services had 4 more articles in the media than AMN Healthcare Services. MarketBeat recorded 4 mentions for West Pharmaceutical Services and 0 mentions for AMN Healthcare Services. West Pharmaceutical Services' average media sentiment score of 0.18 beat AMN Healthcare Services' score of 0.00 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company	Overall Sentiment
AMN Healthcare Services	Neutral
West Pharmaceutical Services	Neutral

West Pharmaceutical Services has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.52	-$95.70M	$2.68	13.74
West Pharmaceutical Services	$3.07B	8.62	$493.70M	$7.81	48.23

West Pharmaceutical Services has a net margin of 16.98% compared to AMN Healthcare Services' net margin of 3.06%. West Pharmaceutical Services' return on equity of 20.11% beat AMN Healthcare Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	3.06%	19.92%	5.93%
West Pharmaceutical Services	16.98%	20.11%	14.83%

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

West Pharmaceutical Services beats AMN Healthcare Services on 14 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to LifeStance Health Group?

LifeStance Health Group (NASDAQ:LFST) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

In the previous week, LifeStance Health Group had 6 more articles in the media than AMN Healthcare Services. MarketBeat recorded 6 mentions for LifeStance Health Group and 0 mentions for AMN Healthcare Services. LifeStance Health Group's average media sentiment score of 0.34 beat AMN Healthcare Services' score of 0.00 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company	Overall Sentiment
LifeStance Health Group	Neutral
AMN Healthcare Services	Neutral

LifeStance Health Group has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	3.28	$9.66M	$0.13	94.00
AMN Healthcare Services	$2.73B	0.52	-$95.70M	$2.68	13.74

LifeStance Health Group presently has a consensus target price of $13.13, indicating a potential upside of 7.41%. AMN Healthcare Services has a consensus target price of $36.00, indicating a potential downside of 2.26%. Given LifeStance Health Group's stronger consensus rating and higher possible upside, equities research analysts clearly believe LifeStance Health Group is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
AMN Healthcare Services	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

LifeStance Health Group has a beta of 1.24, indicating that its stock price is 24% more volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, indicating that its stock price is 60% less volatile than the broader market.

LifeStance Health Group has a net margin of 3.19% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
AMN Healthcare Services	3.06%	19.92%	5.93%

Summary

LifeStance Health Group beats AMN Healthcare Services on 12 of the 17 factors compared between the two stocks.

Get AMN Healthcare Services News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AMN vs. The Competition

Export

Metric	AMN Healthcare Services	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$1.42B	$9.81B	$7.10B	$22.98B
Dividend Yield	N/A	2.61%	2.54%	3.73%
P/E Ratio	13.71	33.98	273.67	28.00
Price / Sales	0.52	4.74	595.47	17.20
Price / Cash	4.42	22.82	27.22	19.10
Price / Book	2.20	5.14	11.09	4.72
Net Income	-$95.70M	$315.68M	$3.49B	$1.07B
7 Day Performance	5.10%	-1.04%	-2.28%	0.89%
1 Month Performance	8.70%	-2.81%	-7.03%	-4.97%
1 Year Performance	85.27%	9.23%	5.66%	5.65%

AMN Healthcare Services Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AMN AMN Healthcare Services	0.9733 of 5 stars	$36.74 -0.3%	$36.00 -2.0%	+79.9%	$1.42B	$2.73B	13.71	2,664
EYE National Vision	3.9568 of 5 stars	$16.12 -2.5%	$29.82 +85.0%	-42.8%	$1.31B	$1.99B	26.43	13,138	Positive News
MEDP Medpace	2.3528 of 5 stars	$615.94 -0.5%	$595.20 -3.4%	+16.5%	$17.27B	$2.53B	36.10	6,200
VEEV Veeva Systems	2.3729 of 5 stars	$280.32 -0.1%	$284.88 +1.6%	-4.4%	$45.44B	$3.20B	46.11	7,928	Insider Trade
WST West Pharmaceutical Services	2.5953 of 5 stars	$375.99 +1.5%	$382.00 +1.6%	+38.3%	$26.07B	$3.07B	48.14	10,800

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AMN) was last updated on 10/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AMN Healthcare Services (AMN) Competitors

AMN vs. EYE, MEDP, VEEV, WST, and LFST

How does AMN Healthcare Services compare to National Vision?

Summary

How does AMN Healthcare Services compare to Medpace?

Summary

How does AMN Healthcare Services compare to Veeva Systems?

Summary

How does AMN Healthcare Services compare to West Pharmaceutical Services?

Summary

How does AMN Healthcare Services compare to LifeStance Health Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMN vs. The Competition

AMN Healthcare Services Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AMN Healthcare Services (AMN) Competitors

AMN vs. EYE, MEDP, VEEV, WST, and LFST

How does AMN Healthcare Services compare to National Vision?

Do analysts rate EYE or AMN?

Does the media refer more to EYE or AMN?

Which has more risk & volatility, EYE or AMN?

Is EYE or AMN more profitable?

Do institutionals & insiders have more ownership in EYE or AMN?

Which has better earnings & valuation, EYE or AMN?

Summary

How does AMN Healthcare Services compare to Medpace?

Is AMN or MEDP more profitable?

Do analysts rate AMN or MEDP?

Does the media refer more to AMN or MEDP?

Do institutionals and insiders have more ownership in AMN or MEDP?

Which has higher valuation & earnings, AMN or MEDP?

Which has more risk and volatility, AMN or MEDP?

Summary

How does AMN Healthcare Services compare to Veeva Systems?

Does the media refer more to AMN or VEEV?

Do analysts rate AMN or VEEV?

Is AMN or VEEV more profitable?

Which has more risk & volatility, AMN or VEEV?

Which has stronger earnings & valuation, AMN or VEEV?

Do institutionals & insiders hold more shares of AMN or VEEV?

Summary

How does AMN Healthcare Services compare to West Pharmaceutical Services?

Which has more volatility & risk, AMN or WST?

Do analysts rate AMN or WST?

Does the media prefer AMN or WST?

Which has better earnings and valuation, AMN or WST?

Is AMN or WST more profitable?

Do institutionals and insiders hold more shares of AMN or WST?

Summary

How does AMN Healthcare Services compare to LifeStance Health Group?

Does the media favor LFST or AMN?

Which has preferable valuation and earnings, LFST or AMN?

Do analysts rate LFST or AMN?

Do insiders and institutionals believe in LFST or AMN?

Which has more risk and volatility, LFST or AMN?

Is LFST or AMN more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMN vs. The Competition

AMN Healthcare Services Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools